8F: BioInterfaces SIG

The Biomaterials and Medical Products Commercialization SIG aims to provide researchers with the necessary tools to take their ideas from concept to physical product to market-ready technology. This session will focus on highlighting the various considerations needed on a product's journey to commercialization including, but not limited to, sterilization and purification, product scale-up and robust manufacturing, product purification, quality control, regulatory considerations, reimbursement strategies, supply chain, and market adoption. Examples will be provided from members of academia and industry, from small start-ups to large organizations, and from numerous markets and end-use applications. This session will hopefully inform and inspire the SFB community as they start and/or continue down the path of product development and commercialization.